Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 68071-3921

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 68071-3921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3921 6)

Label for Quetiapine Extended Release 50 mg oral tablets by NuCare Pharmaceuticals, Inc. The label indicates 60 extended-release tablets per bottle with a dosage of 50 mg quetiapine fumarate equivalent. It includes manufacturer information, barcode, and storage instructions stating to keep at controlled temperature 68-77°F and out of reach of children.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Fig01)

A line graph depicting the proportion of patients with relapse (%) over time in months. Two groups are compared: PLA (placebo) and QTP XR (quetiapine extended release). The graph shows higher relapse rates in the placebo group across the 7-month period compared to the quetiapine extended release group.*

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Fig02)

A line graph depicting the proportion of patients with relapse (%) over time in weeks. The graph compares two groups labeled as CTP+LIVAL and PLA+LIVAL, showing their relapse rates across a 100-week period.*

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Fig03)

A line graph depicting the proportion of patients with relapse over time (in weeks) comparing Quetiapine (QTP) plus LiVAl treatment versus placebo (PLA) plus LiVAl treatment. The Y-axis represents the proportion of patients with relapse (%) ranging from 0 to 100, and the X-axis shows time in weeks up to 100 weeks. Two separate stepwise lines indicate relapse progression in each treatment group.*

FDA Label Image

Structural Formula (Quetiapine Str)

Chemical structure diagram showing the molecular structure of quetiapine fumarate, the active ingredient in Quetiapine Extended Release tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.